PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3303585

A linear array system for deep vessel explorations.

M Berson·A Roncin·P Arbeille·F Patat·L Pourcelot
View original source ↗Export metadata ↓

Abstract

A system for the exploration of deep vessels is proposed. This device is based on a single 300 element linear array in which a "Doppler area" is selected to electronically steer a Doppler beam. Characteristics of the equipment are excellent and it is as easy to handle as a simple linear array scanner. A real-time spectrum analyser is used to process the Doppler signals. The probe and the associated electronics are described and some results are given to illustrate the capabilities of the device such as blood flow estimation and deep vessel studies.

Explore related subjects

AortaBlood VesselsEquipment DesignFemaleFetusHumansMathematicsPregnancyRegional Blood FlowUltrasonographyVascular DiseasesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Berson, A Roncin, P Arbeille, F Patat, L Pourcelot. 1987. A linear array system for deep vessel explorations.. https://doi.org/10.1016/0301-5629(87)90099-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Identification of a novel 85-kDa lipoprotein lipase binding protein on human aortic endothelial cell surface.

Lipoprotein lipase (LPL), bound to the luminal surface of vascular endothelium catalyzes lipoprotein triglyceride hydrolysis. Studies were performed to identify human aortic endothelial (HAEC) cell-surface proteins having high affinity for LPL. LPL-sepharose affinity chromatography of [35S]O4 labeled HAEC proteins identified a 220-kDa proteoglycan. Ligand blotting of HAEC plasma membrane proteins with LPL revealed two specific binding proteins of MW 116 kDa and 85 kDa, respectively, which were not released from the cell-surface by heparin treatment. Since the 220-kDa and 116-kDa proteins have been reported previously in bovine endothelial cells, we focused on the 85-kDa protein. The 85-kDa protein was not labelled by incubation of the cells with [35S]O4, suggesting that it is not a sulfated proteoglycan. Treatment of HAEC with tunicamycin markedly decreased detection of the 85-kDa protein, suggesting that it is likely a glycoprotein synthesized by HAEC. We conclude that HAEC cell surface has three specific LPL binding proteins, a 220-kDa proteoglycan, a 116-kDa protein and a novel 85-kDa protein.

Aorta↗
PubMed1995

Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation.

BACKGROUND: Orthotopic cardiac transplantation results in total cardiac denervation. Recent studies in humans suggest that reinnervation of cardiac sympathetic nerves (cardiac efferents) may occur after cardiac transplantation. We hypothesized that reinnervation of cardiac afferents may occur as well. To test this hypothesis, we investigated reflex responses produced by stimulation of ventricular chemosensory endings subserved by vagal afferents (cardiac depressor reflex). METHODS AND RESULTS: Two cardiac transplant groups were studied: an "early" group (n = 18, < 24 months after transplant) and a "late" group (n = 18, > 43 months after transplant); these groups were compared with a control group with intact innervation (n = 18). The reflex response of the recipient sinus node (RSN) in the remnant right atrium, which remains innervated after transplantation, was observed during selective right coronary artery (RCA) and left coronary artery (LCA) injection of the radiographic contrast agent meglumine diatrizoate, which is known to stimulate ventricular chemosensory endings. A decrease in the rate of the RSN was expected if reinnervation of chemosensory endings had occurred and the afferent limb of the cardiac depressor reflex was intact. With injection, the RSN rate of both transplant groups did not decrease but increased (early: LCA, 7.2 +/- 1.4 beats per minute; RCA, 6.3 +/- 1.3 beats per minute; late: LCA, 5.9 +/- 1.0 beats per minute; RCA, 6.0 +/- 0.9 beats per minute) compared with the expected decrease in control patients (LCA, -20.8 +/- 2.5 beats per minute; RCA, -18.0 +/- 4.0 beats per minute; P < .001 versus transplants). Decreases in mean arterial pressure in the transplant groups (early: LCA, -11.3 +/- 1.4 mm Hg; RCA, -10.0 +/- 1.6 mm Hg; late: LCA, -13.0 +/- 1.6 mm Hg; RCA, -9.1 +/- 1.5 mm Hg) were less than those observed in the control group (LCA, -19.8 +/- 2.2 mm Hg; RCA, -18.7 +/- 4.0 mm Hg; P < .05 versus transplants). CONCLUSIONS: The results suggest that reinnervation of ventricular chemosensory endings subserved by vagal afferents in cardiac transplant patients does not occur up to 74 months after transplantation.

Aorta↗